• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS SYPHILIS; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS SYPHILIS; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Model Number SYPHILIS
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/18/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received a discrepant result for one patient sample tested with elecsys syphilis on a cobas 6000 e 601 module.The sample was aliquoted into two tubes.One tube of sample was diluted 1/10 and tested with an unknown fta-abs igm antibody test, resulting with a (b)(6) value on (b)(6) 2019.The second tube of sample was tested on the e 601 analyzer on (b)(6) 2019, resulting with a value of (b)(6), which was reported outside of the laboratory.On (b)(6) 2019, the patient's syphilis result was (b)(6).The serial number of the e 601 analyzer is (b)(4).
 
Manufacturer Narrative
Calibration signals were within expected ranges.Quality controls tested on (b)(6) 2019 and (b)(6) 2019 were within range.Of the provided quality control data, all results were within specified ranges.Upon review of the alarm trace, no relevant alarms were observed on (b)(6) 2019.Two samples from the patient were provided for investigation.The results obtained by the customer could be duplicated.The sample was non reactive for the elecsys syphilis assay and was reaction for tpla and rpr.The sample showed reactivity against specific igm antibodies and no reactivity against specific igg antibodies.Taking all results into account, the sample was derived from an early syphilis seroconversion.The elecsys syphilis results are still non-reactive (approximately at 0.8 coi), however all results are close to the cut-off value of 1.0 coi.For diagnostic purposes, the results should always be assessed in conjunction with the patient's medical history, clinical examination and other findings.Per product labeling: "a negative test result does not completely rule out the possibility of an infection with syphilis.Serum or plasma samples from the very early (preseroconversion) phase or the late phase of a syphilis infection can occasionally yield negative findings." the elecsys syphilis assay performs within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS SYPHILIS
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9401988
MDR Text Key219135793
Report Number1823260-2019-04184
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
PMA/PMN Number
K160910
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2019
Device Model NumberSYPHILIS
Device Catalogue Number06923348190
Device Lot Number37025101
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 11/04/2019
Initial Date FDA Received12/03/2019
Supplement Dates Manufacturer Received11/04/2019
Supplement Dates FDA Received03/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age33 YR
-
-